Great update today at the Proactive One2One Invest
Post# of 1418
(Total Views: 274)
Posted On: 03/17/2022 4:23:24 PM
Great update today at the Proactive One2One Investor Forum
A little like speed dating in 20 minutes compared to yesterday's 90 minutes with about 5-10 minutes for questions.
It seemed Dr Janet Massey maybe needs a 1-on-1 with all the questions she had unless that was Dr. JPeckerhead's sister. Seem from EU.
The questions below are in reverse order. The funniest one that was asked by Drew that I think was deleted, was in response to Dr Janet Massey that fired off a bunch of questions.
"Do you like chatting with yourself?"
That cracked me up.
Was very little time to answer questions. My comments in red.
Question from David Korr: When will the Phase2/3 Tollivir testing begin?
I think you mean Tollovir trial, not Tollivir testing but everyone got the question. Gerald didn't have time to answer and better than Dr. ChitChat's questions. My take is, you have to design the trial, get approval, blah, blah, blah. Not something that's going to happen less than 2 months after the data is announced. Remember they are still getting data.
People keep asking GC to give dates that are impossible to give since he doesn't control everything outside the company. He could say this year, but that would upset some.
Question from Anthony Fazio: Now that 3CL deal is closed when will you be purchasing personal shares as well as doing a buyback as mentioned in the past?
The deal just closed. Let the ink dry. Doesn't matter to me anyway if he does or not. Seems like this question gets asked to every company. Not sure why. If that is super inportant then just invest only in companies where there is large insider buying.
The next complaint would be, Gerald didn't buy enough shares or everyone at the entire company didn't buy. Isn't there more important questions to ask? Gerald gets asked the most stupidest questions on Twitter as well.
Question from David Korr: How many pcr tests did Provista lab do this past February?
Good question. Gerald did have time to answer. Testing will be up & down no doubt. While Gerald didn't say it on the call, the next wave will start shortly in the US. I think investors will be able to predict sales based on cases. The lulls in testing will knock some of the competition out.
Rest of the questions below were all in the Q&A early on from Dr Janet Massey. The mod probably read a few and... DELETE. Maybe has a history of trolling? The wealth inhibitor advisor company has a product for you.
Question from Dr Janet Massey: One study from one centre is insufficient for what I hear being claimed......
uhmmm, there was a number of studies, but not sure if you are talking about Tollovid, Tollovir, Trollovid, etc. But yes, I think Todos gets it and for countries that need a phase 2/3, that is in the planning phase. Now if you are saying there will never be a EUA. Join Sapnoliver that is posting his life a way.
Question from Dr Janet Massey: OTC products also have to have very strong evidence-base of effectivity to justify prices of hundreds of dollars. What does Mytollovid have and where it is published?
Right. Gerald didn't say it's done. I think it's just starting. If it happens this year cool. If not, life goes on and keep selling Tollovid at $200/bottle. As Gerald said, a lot of $ have gone into the R&D.
Question from Dr Janet Massey: How does the training as a Professional Footballer assist him in his present position?
That's a JPeckerhead question for sure and exposes an 'agenda' or bias
Question from Dr Janet Massey: Perhaps he would like to describe his Board? How many women and how many Profs in clinical positions?
Perhaps the google machine could help you! Look, there are ladies at Todos!
https://todosmedical.com /
Question from Dr Janet Massey: Does Mr Commissiong know that the NHS will negotiate very stringent terms for his products which may mean that the high profits he is extolling may not be available?
Right. The NHS negotiated such great terms for the other products that cost $3,000. Heck, let's just give it away for free.
Question from Dr Janet Massey: So which was the product used in the German Nursing homes that did not induce a high enough response?
Huh? Are you on the right call?
A little like speed dating in 20 minutes compared to yesterday's 90 minutes with about 5-10 minutes for questions.
It seemed Dr Janet Massey maybe needs a 1-on-1 with all the questions she had unless that was Dr. JPeckerhead's sister. Seem from EU.
The questions below are in reverse order. The funniest one that was asked by Drew that I think was deleted, was in response to Dr Janet Massey that fired off a bunch of questions.
"Do you like chatting with yourself?"
That cracked me up.
Was very little time to answer questions. My comments in red.
Question from David Korr: When will the Phase2/3 Tollivir testing begin?
I think you mean Tollovir trial, not Tollivir testing but everyone got the question. Gerald didn't have time to answer and better than Dr. ChitChat's questions. My take is, you have to design the trial, get approval, blah, blah, blah. Not something that's going to happen less than 2 months after the data is announced. Remember they are still getting data.
People keep asking GC to give dates that are impossible to give since he doesn't control everything outside the company. He could say this year, but that would upset some.
Question from Anthony Fazio: Now that 3CL deal is closed when will you be purchasing personal shares as well as doing a buyback as mentioned in the past?
The deal just closed. Let the ink dry. Doesn't matter to me anyway if he does or not. Seems like this question gets asked to every company. Not sure why. If that is super inportant then just invest only in companies where there is large insider buying.
The next complaint would be, Gerald didn't buy enough shares or everyone at the entire company didn't buy. Isn't there more important questions to ask? Gerald gets asked the most stupidest questions on Twitter as well.
Question from David Korr: How many pcr tests did Provista lab do this past February?
Good question. Gerald did have time to answer. Testing will be up & down no doubt. While Gerald didn't say it on the call, the next wave will start shortly in the US. I think investors will be able to predict sales based on cases. The lulls in testing will knock some of the competition out.
Rest of the questions below were all in the Q&A early on from Dr Janet Massey. The mod probably read a few and... DELETE. Maybe has a history of trolling? The wealth inhibitor advisor company has a product for you.
Question from Dr Janet Massey: One study from one centre is insufficient for what I hear being claimed......
uhmmm, there was a number of studies, but not sure if you are talking about Tollovid, Tollovir, Trollovid, etc. But yes, I think Todos gets it and for countries that need a phase 2/3, that is in the planning phase. Now if you are saying there will never be a EUA. Join Sapnoliver that is posting his life a way.
Question from Dr Janet Massey: OTC products also have to have very strong evidence-base of effectivity to justify prices of hundreds of dollars. What does Mytollovid have and where it is published?
Right. Gerald didn't say it's done. I think it's just starting. If it happens this year cool. If not, life goes on and keep selling Tollovid at $200/bottle. As Gerald said, a lot of $ have gone into the R&D.
Question from Dr Janet Massey: How does the training as a Professional Footballer assist him in his present position?
That's a JPeckerhead question for sure and exposes an 'agenda' or bias
Question from Dr Janet Massey: Perhaps he would like to describe his Board? How many women and how many Profs in clinical positions?
Perhaps the google machine could help you! Look, there are ladies at Todos!
https://todosmedical.com /
Question from Dr Janet Massey: Does Mr Commissiong know that the NHS will negotiate very stringent terms for his products which may mean that the high profits he is extolling may not be available?
Right. The NHS negotiated such great terms for the other products that cost $3,000. Heck, let's just give it away for free.
Question from Dr Janet Massey: So which was the product used in the German Nursing homes that did not induce a high enough response?
Huh? Are you on the right call?
(1)
(0)Todos Med Ltd. (TOMDF) Stock Research Links
Scroll down for more posts ▼